Paula Chu

1.3k total citations
19 papers, 525 citations indexed

About

Paula Chu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Paula Chu has authored 19 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Economics and Econometrics. Recurrent topics in Paula Chu's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Paula Chu is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). Paula Chu collaborates with scholars based in United States, United Kingdom and Switzerland. Paula Chu's co-authors include Sue J. Goldie, M. G. Myriam Hunink, Gloria Y. Yeh, Rinske A. Gotink, Alan M. Zaslavsky, Sengwee Toh, Laura F. Garabedian, Stephen B. Soumerai, Ankur Pandya and Milton C. Weinstein and has published in prestigious journals such as Annals of Internal Medicine, Medicine and Health Technology Assessment.

In The Last Decade

Paula Chu

18 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paula Chu United States 12 92 89 79 70 62 19 525
Pranav Gandhi United States 13 60 0.7× 54 0.6× 37 0.5× 73 1.0× 37 0.6× 56 515
Pearl Lee United States 13 83 0.9× 54 0.6× 25 0.3× 68 1.0× 36 0.6× 33 838
Gerardo Machnicki United States 15 47 0.5× 93 1.0× 43 0.5× 162 2.3× 55 0.9× 42 790
Varalak Srinonprasert Thailand 15 88 1.0× 44 0.5× 67 0.8× 67 1.0× 28 0.5× 79 630
Rachel Halpern United States 15 22 0.2× 96 1.1× 36 0.5× 147 2.1× 92 1.5× 42 822
Clémentine Nordon United Kingdom 16 77 0.8× 63 0.7× 83 1.1× 29 0.4× 254 4.1× 66 679
Shayan Shirazian United States 12 54 0.6× 32 0.4× 70 0.9× 64 0.9× 120 1.9× 26 740
Raquel Lahoz Switzerland 19 307 3.3× 73 0.8× 48 0.6× 62 0.9× 53 0.9× 53 859
Niklas Bergvall Switzerland 17 55 0.6× 80 0.9× 42 0.5× 21 0.3× 173 2.8× 32 1.1k
André Fattori Brazil 15 105 1.1× 90 1.0× 33 0.4× 36 0.5× 36 0.6× 55 692

Countries citing papers authored by Paula Chu

Since Specialization
Citations

This map shows the geographic impact of Paula Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Chu more than expected).

Fields of papers citing papers by Paula Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Chu. The network helps show where Paula Chu may publish in the future.

Co-authorship network of co-authors of Paula Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Chu. A scholar is included among the top collaborators of Paula Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Chu. Paula Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chu, Paula, et al.. (2024). Clinical Efficacy and Safety of Treatments for Exocrine Pancreatic Insufficiency: A Systematic Literature Review. Digestion. 106(1). 1–17. 3 indexed citations
2.
3.
Chu, Paula, et al.. (2020). Systematic review of neurotrophic tropomyosin-related kinase inhibition as a tumor-agnostic management strategy. Future Oncology. 16(4). 61–74. 11 indexed citations
4.
Chu, Paula, et al.. (2020). Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer. Journal of Comparative Effectiveness Research. 9(12). 861–876. 11 indexed citations
5.
Conter, Henry Jacob, Scott Owen, Anna Zhou, et al.. (2019). Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC). Journal of Medical Economics. 22(7). 625–637. 25 indexed citations
6.
Schulz, Christian, David Gandara, Carmen Galani Berardo, et al.. (2019). Comparative Efficacy of Second- and Subsequent-line Treatments for Metastatic NSCLC: A Fractional Polynomials Network Meta-analysis of Cancer Immunotherapies. Clinical Lung Cancer. 20(6). 451–460.e5. 10 indexed citations
7.
O’Hara, Jamie, et al.. (2018). Long‐term outcomes from prophylactic or episodic treatment of haemophilia A: A systematic review. Haemophilia. 24(5). e301–e311. 20 indexed citations
8.
Chu, Paula, et al.. (2017). Fractional Polynomial Modelling In Network Meta-Analyses Of Cancer Immunotherapies In Advanced Non-Small Cell Lung Cancer (NSCLC). Value in Health. 20(9). A757–A757. 2 indexed citations
9.
Chu, Paula, Ankur Pandya, Joshua A. Salomon, Sue J. Goldie, & M. G. Myriam Hunink. (2016). Comparative Effectiveness of Personalized Lifestyle Management Strategies for Cardiovascular Disease Risk Reduction. Journal of the American Heart Association. 5(3). e002737–e002737. 43 indexed citations
10.
Garabedian, Laura F., Paula Chu, Sengwee Toh, Alan M. Zaslavsky, & Stephen B. Soumerai. (2014). Potential Bias of Instrumental Variable Analyses for Observational Comparative Effectiveness Research. Annals of Internal Medicine. 161(2). 131–138. 93 indexed citations
11.
Chu, Paula, Rinske A. Gotink, Gloria Y. Yeh, Sue J. Goldie, & M. G. Myriam Hunink. (2014). The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. European Journal of Preventive Cardiology. 23(3). 291–307. 153 indexed citations
12.
Wagner, Monika, Mireille Goetghebeur, Elizabeth Merikle, et al.. (2009). Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.. PubMed. 16(2). e331–45. 13 indexed citations
13.
O’Sullivan, Amy K., David R. Thompson, Paula Chu, et al.. (2009). Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids. International Journal of Technology Assessment in Health Care. 25(1). 14–25. 48 indexed citations
14.
15.
Taylor, Douglas C.A., Paula Chu, Virginia M. Rosen, Christine L. Baker, & David Thompson. (2008). Budgetary Impact of Varenicline in Smoking Cessation in the United Kingdom. Value in Health. 12(1). 28–33. 11 indexed citations
16.
Taylor, Douglas C.A., Ankur Pandya, David R. Thompson, et al.. (2008). Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study. The European Journal of Health Economics. 10(3). 255–265. 30 indexed citations
17.
Pandya, Ankur, David R. Thompson, Paula Chu, et al.. (2007). PO16-439 COST-EFFECTIVENESS OF INTENSIVE LIPID-LOWERING TREATMENT IN SECONDARY CARDIOVASCULAR PREVENTION IN SPAIN AND GERMANY. Atherosclerosis Supplements. 8(1). 125–125. 1 indexed citations
18.
Weinstein, Milton C., et al.. (2007). OC29: Cost‐effectiveness of magnetic resonance image‐guided focused ultrasound (MRgFUS) for the treatment of uterine fibroids. Ultrasound in Obstetrics and Gynecology. 30(4). 376–376. 1 indexed citations
19.
Pandya, Ankur, David R. Thompson, Paula Chu, et al.. (2006). Mo-P5:344 Cost-effectiveness of intensive lipid-lowering treatment with atorvastatin 80MG versus 10MG in secondary cardiovascular prevention in the UK. Atherosclerosis Supplements. 7(3). 121–121.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pranav Gandhi Breakdown of academic impact, for papers by Pearl Lee Breakdown of academic impact, for papers by Gerardo Machnicki Breakdown of academic impact, for papers by Varalak Srinonprasert Breakdown of academic impact, for papers by Rachel Halpern Breakdown of academic impact, for papers by Clémentine Nordon Breakdown of academic impact, for papers by Shayan Shirazian Breakdown of academic impact, for papers by Raquel Lahoz Breakdown of academic impact, for papers by Niklas Bergvall Breakdown of academic impact, for papers by André Fattori
Rankless by CCL
2026